HederaDX
Hedera Dx | Modern cancer care for the next billion people
- Headquarters
- Epalinges
- Business Model
- B2B
- Website
- hederadx.com
- Last Round
- Series AMay 2025
- Rounds
- 2
About
Mission to simplify cancer testing
Summary
HederaDX is a Biotech company based in Epalinges, Switzerland. Its most recent funding was a Series A round in May 2025. Investors include Vsquared Ventures, General Catalyst and 7wireVentures.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2025
Sign up to see all 2 rounds
Seed through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/hederadx"><img src="https://indexed.vc/api/badge/company/hederadx" alt="HederaDX on Indexed.vc" width="260" height="76" /></a>